Your browser doesn't support javascript.
loading
Asprosin inhibits macrophage lipid accumulation and reduces atherosclerotic burden by up-regulating ABCA1 and ABCG1 expression via the p38/Elk-1 pathway.
Zou, Jin; Xu, Can; Zhao, Zhen-Wang; Yin, Shan-Hui; Wang, Gang.
Afiliación
  • Zou J; The First Affiliated Hospital, Department of Cardiology, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, People's Republic of China.
  • Xu C; The First Affiliated Hospital, Department of Cardiology, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, People's Republic of China.
  • Zhao ZW; Institute of Cardiovascular Disease, Key Lab for Arteriosclerology of Hunan Province, Hunan International Scientific and Technological Cooperation Base of Arteriosclerotic Disease, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang Medical School, University o
  • Yin SH; The First Affiliated Hospital, Department of Neonatology, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, People's Republic of China.
  • Wang G; The First Affiliated Hospital, Department of Cardiology, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, People's Republic of China. 783224908@qq.com.
J Transl Med ; 20(1): 337, 2022 07 28.
Article en En | MEDLINE | ID: mdl-35902881

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Aterosclerosis / Placa Aterosclerótica Límite: Animals Idioma: En Revista: J Transl Med Año: 2022 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Aterosclerosis / Placa Aterosclerótica Límite: Animals Idioma: En Revista: J Transl Med Año: 2022 Tipo del documento: Article